Advertisement
For patients with hyperhidrosis

Botulinum Toxin Ups Physical, Mental Health in Hyperhidrosis

0
Reductions in sweat-related health problems, anxiety and depression, symptom severity
Briviact (brivaracetam) has been approved by the U.S. Food and Drug Administration to treat partial onset seizures in people aged 16 and older with epilepsy.

FDA Approves Briviact for Partial Onset Seizures

0
Drug sanctioned for epilepsy patients aged 16 and older
Stroke survivors receive an average of 22 hours of caregiving per week

ASA: Stroke Caregiving Costs Higher Than Previously Thought

0
Average annual cost for caregiving for elderly stroke survivor estimated at $11,300
A considerable proportion of patients with stroke develop a seizure

ASA: Long-Term Seizure Risk for Patients With Stroke

0
Substantial proportion of patients with stroke develop seizure; similar rate to that in TBI patients
For patients with carotid artery stenosis

ASA: Stenting, Endarterectomy Similar in Carotid Artery Stenosis

0
Two studies show similar short- and long-term outcomes for stenting versus surgery
Most medical schools need to post

Many Med Schools Appear Unwelcoming Regarding Disability

0
Only one-third of medical schools have technical standards supporting accommodating disabilities
For patients with insulin resistance with recent stroke or transient ischemic attack

ASA: Pioglitazone After Stroke, TIA Helpful in Insulin Resistance

0
Linked to reduction in risk of stroke, myocardial infarction in patients with insulin resistance
Pregnancy at an advanced age is associated with increased risk of hemorrhagic stroke after menopause

ASA: Pregnancy at Advanced Age Ups Hemorrhagic Stroke Risk

0
After adjustment for multiple variables, significantly increased risk in postmenopausal women
A long-term study shows that little progress has been made in the prevention of epilepsy in Finland over the past 40 years. The findings were published online Feb. 15 in JAMA Neurology.

Little Progress Made in Preventing New-Onset Epilepsy

0
Finnish study also shows significant increase in new-onset epilepsy among the elderly
The U.S. Preventive Services Task Force concludes that the evidence is currently insufficient to weigh the balance of benefits and harms of screening for autism spectrum disorder (ASD) in young children for whom no concerns of ASD have been raised. These findings form the basis of a recommendation statement published in the Feb. 16 issue of the Journal of the American Medical Association.

USPSTF: Evidence Lacking for Routine Use of ASD Screening

0
Insufficient evidence to assess benefits, harms of screening for children in whom no concerns raised